Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography

Chris H. Takimoto, Raymond W. Klecker, William L. Dahut, Lorrin K. Yee, John M. Strong, Carmen J. Allegra, Jean L Grem

Research output: Contribution to journalArticle

62 Citations (Scopus)

Abstract

We have developed a sensitive HPLC assay to quantitate the active lactone form of 9-aminocamptothecin (9AC) in human plasma over the concentration range 10-0.25 nM (0.091 ng/ml). Solid-phase extraction separated 9AC lactone from its less active metabolite, 9AC carboxylate, allowing samples to be stored for up to two months prior to reversed-phase HPLC analysis. An acidic (pH 2.55) isocratic HPLC mobile phase was used to enhance 9AC fluorescence resulting in an over 50-fold increase in assay sensitivity compared to previous methods. This assay was able to measure steady-state 9AC lactone concentrations even at the lowest dose level of 9AC used in our Phase I clinical trial.

Original languageEnglish (US)
Pages (from-to)97-104
Number of pages8
JournalJournal of Chromatography B: Biomedical Sciences and Applications
Volume655
Issue number1
DOIs
StatePublished - Apr 22 1994

Fingerprint

9-aminocamptothecin
High performance liquid chromatography
Lactones
Plasmas
Assays
Plasma (human)
Metabolites
Fluorescence

ASJC Scopus subject areas

  • Chemistry(all)

Cite this

Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography. / Takimoto, Chris H.; Klecker, Raymond W.; Dahut, William L.; Yee, Lorrin K.; Strong, John M.; Allegra, Carmen J.; Grem, Jean L.

In: Journal of Chromatography B: Biomedical Sciences and Applications, Vol. 655, No. 1, 22.04.1994, p. 97-104.

Research output: Contribution to journalArticle

Takimoto, Chris H. ; Klecker, Raymond W. ; Dahut, William L. ; Yee, Lorrin K. ; Strong, John M. ; Allegra, Carmen J. ; Grem, Jean L. / Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography. In: Journal of Chromatography B: Biomedical Sciences and Applications. 1994 ; Vol. 655, No. 1. pp. 97-104.
@article{9a5f005dc1bf4014951740b0ccb8dcf2,
title = "Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography",
abstract = "We have developed a sensitive HPLC assay to quantitate the active lactone form of 9-aminocamptothecin (9AC) in human plasma over the concentration range 10-0.25 nM (0.091 ng/ml). Solid-phase extraction separated 9AC lactone from its less active metabolite, 9AC carboxylate, allowing samples to be stored for up to two months prior to reversed-phase HPLC analysis. An acidic (pH 2.55) isocratic HPLC mobile phase was used to enhance 9AC fluorescence resulting in an over 50-fold increase in assay sensitivity compared to previous methods. This assay was able to measure steady-state 9AC lactone concentrations even at the lowest dose level of 9AC used in our Phase I clinical trial.",
author = "Takimoto, {Chris H.} and Klecker, {Raymond W.} and Dahut, {William L.} and Yee, {Lorrin K.} and Strong, {John M.} and Allegra, {Carmen J.} and Grem, {Jean L}",
year = "1994",
month = "4",
day = "22",
doi = "10.1016/0378-4347(94)00051-4",
language = "English (US)",
volume = "655",
pages = "97--104",
journal = "Journal of Chromatography B: Biomedical Sciences and Applications",
issn = "1387-2273",
publisher = "Elsevier BV",
number = "1",

}

TY - JOUR

T1 - Analysis of the active lactone form of 9-aminocamptothecin in plasma using solid-phase extraction and high-performance liquid chromatography

AU - Takimoto, Chris H.

AU - Klecker, Raymond W.

AU - Dahut, William L.

AU - Yee, Lorrin K.

AU - Strong, John M.

AU - Allegra, Carmen J.

AU - Grem, Jean L

PY - 1994/4/22

Y1 - 1994/4/22

N2 - We have developed a sensitive HPLC assay to quantitate the active lactone form of 9-aminocamptothecin (9AC) in human plasma over the concentration range 10-0.25 nM (0.091 ng/ml). Solid-phase extraction separated 9AC lactone from its less active metabolite, 9AC carboxylate, allowing samples to be stored for up to two months prior to reversed-phase HPLC analysis. An acidic (pH 2.55) isocratic HPLC mobile phase was used to enhance 9AC fluorescence resulting in an over 50-fold increase in assay sensitivity compared to previous methods. This assay was able to measure steady-state 9AC lactone concentrations even at the lowest dose level of 9AC used in our Phase I clinical trial.

AB - We have developed a sensitive HPLC assay to quantitate the active lactone form of 9-aminocamptothecin (9AC) in human plasma over the concentration range 10-0.25 nM (0.091 ng/ml). Solid-phase extraction separated 9AC lactone from its less active metabolite, 9AC carboxylate, allowing samples to be stored for up to two months prior to reversed-phase HPLC analysis. An acidic (pH 2.55) isocratic HPLC mobile phase was used to enhance 9AC fluorescence resulting in an over 50-fold increase in assay sensitivity compared to previous methods. This assay was able to measure steady-state 9AC lactone concentrations even at the lowest dose level of 9AC used in our Phase I clinical trial.

UR - http://www.scopus.com/inward/record.url?scp=0028256230&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028256230&partnerID=8YFLogxK

U2 - 10.1016/0378-4347(94)00051-4

DO - 10.1016/0378-4347(94)00051-4

M3 - Article

VL - 655

SP - 97

EP - 104

JO - Journal of Chromatography B: Biomedical Sciences and Applications

JF - Journal of Chromatography B: Biomedical Sciences and Applications

SN - 1387-2273

IS - 1

ER -